ArticleCureus2025
Examining Medicare Reimbursement Differences for Cochlear Implant Surgery.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives This study aims to investigate discrepancies in Medicare reimbursements for cochlear implant surgery between the hospital setting and ambulatory surgery centers (ASCs), which provide a convenient alternative to hospital-based outpatient procedures by offering same-day surgical healthcare. Study design A retrospective analysis of Medicare claims data from 2019 to 2021 was conducted, including 358 otolaryngology and ASC providers. The study evaluated average Medicare reimbursement for cochlear implantation procedures performed in ASCs using Current Procedural Terminology (CPT) code 69930 and compared these with reimbursements for the same procedure in outpatient hospital settings using Ambulatory Payment Classification (APC) code 5166. Methods The primary outcome variable was the average Medicare reimbursement amount for each provider location (ASCs vs. outpatient hospital setting) for each code associated with cochlear implant surgery. Unpaired two-tailed t-tests (p <0.05) were used to compare average reimbursement amounts between the two groups. Additionally, box-and-whisker plots were utilized to illustrate the distribution of reimbursement amounts between each provider group. Results Outpatient hospital settings received significantly greater reimbursements for cochlear implant surgery between 2019 and 2021 (for 2019, mean = 29595.58, SD = 3934.898; for 2020, mean = 31464.87, SD = 4177.054; for 2021, mean = 32549.87, SD = 4402.242) compared with ASCs(for 2019, mean = 23202.01, SD = 2242.805, p < 0.0001; for 2020, mean = 24986.88, p < 0.001, SD = 3367.238; for 2021, mean = 26028.86, SD = 3184.769, p < 0.0001). Conclusions Identifying discrepancies in Medicare reimbursement for cochlear implant surgery between ASC surgeons and outpatient settings is crucial for understanding treatment selection. This study investigates current reimbursement practices and highlights areas for potential improvement within the Medicare system. Further research may explore reasons for reimbursement variations and their impact on patients needing cochlear implants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.